Document is current
Any future updates will be listed below
-
Authors
Chu, Yankai
Chen, Shishuang
Yang, Mingyang
Chen, Yin
Fang, Huiling
Huang, Pinyu
Xie, Yueru
Sun, Chi
Chen, Yun
Zhang, Baoding
Li, Li
Mu, Hongchen
Song, Ding
Cheng, Wentao
Wang, Chao
Jiang, Wei
Xu, Xiaolan
He, Zhengjin
Chen, Shuo
Liu, Mingxian
Ma, Jingchuan
Yang, Man
Cao, Jiaqi
Gao, Jing
Shen, Jiali
Zhang, Lulu
Bai, Yu
Liu, Zheyi
Chen, Jingyao
Dai, Siqi
Zeng, Yi Arial
Zhao, Yun https://orcid.org/0000-0002-7807-6094
Zhou, Hu https://orcid.org/0000-0001-7006-4737
Chen, Chong https://orcid.org/0000-0002-6787-0495
Ru, Huanwei
Tan, Li https://orcid.org/0000-0002-1199-9046
Chi, Ximin https://orcid.org/0000-0002-3839-5998
Wang, Fangjun https://orcid.org/0000-0002-8118-7019
Gao, Daming
Lin, Moubin
Deng, Xianming https://orcid.org/0000-0002-9354-5864
Jiang, Hai https://orcid.org/0000-0002-2508-5413
- License Information
-
More Information
Article History
Received: 7 March 2025
Accepted: 24 July 2025
First Online: 10 September 2025
Competing interests
: H.J., D.X., Y.Y., S.C., Y.C. and H.F. are co-inventors of patent applications based on this study. H.J., Y.C., Y.X., C.W., W.J., Z.H., M.L., H.R. and J.M. hold equity in or are employees of Defandtx, which works on developing MGD drugs. The other authors declare no competing interests.
